Karyopharm Therapeutics (KPTI) Financials: Revenue & Earnings

KPTI price $0.56 +0.08 +16.88%

Ticker
KPTI
Price
$0.56
Change
+0.08 +16.88%
Market cap ?
$12.72M
P/E ?
-0.02
Forward P/E ?
0.78
Dividend yield ?
0.00%
Beta ?
1.04
Sector
Healthcare
Industry
Biotechnology

Financials

2016201720182019202020212022202320242025
15400016050003033600040893000108085000209819000157074000146033000145237000146067000

Karyopharm Therapeutics Inc. is a pharmaceutical company that has already brought products to market, focusing on identifying, advancing, and selling medications designed to disrupt nuclear export pathways. These drugs are primarily aimed at treating cancer and various other illnesses. The company's strategy involves researching, creating, and marketing innovative Selective Inhibitor of Nuclear Export (SINE)…

Fair value

KPTI fair value $28.15. Price $0.56. Price is 98% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare KPTI

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-02—-0.95—33.54M
2026-08-13-2.32-1.3733.43M32.19M
2026-05-14-1.24-1.4535.07M31.40M
2026-02-12-5.68-2.2634.08M35.10M
2025-11-03-3.82-3.4744.04M42.06M
2025-08-11-4.32-3.8037.93M38.03M
2025-05-12-2.77-4.2130.02M35.12M
2025-02-19-3.60-0.2530.54M35.67M
2024-11-05-3.90-3.9438.78M37.92M
2024-08-06-3.00-4.3542.79M36.21M
2024-05-08-4.80-4.9533.13M34.48M
2024-02-29-5.40-0.3133.75M35.40M
2023-11-02-4.50-4.2036.01M37.27M
2023-08-02-4.35-5.1037.58M35.67M
2023-05-04-4.50-0.3738.70M36.32M
2023-02-15-0.43-0.3533.58M34.43M
2022-11-03-0.45-8.4036.15M34.83M
2022-08-04-0.62-9.4539.68M35.96M
2022-05-05-0.53-9.4547.67M34.41M
2022-02-080.46-6.00126.27M52.71M
2021-11-03-0.69-10.1937.69M25.80M
2021-08-05-0.71-10.7922.60M22.60M
2021-05-03-0.77-10.4923.26M26.57M
2021-02-11-0.59-8.7035.10M27.37M
2020-11-02-10.94-10.9421.33M21.04M
2020-08-04-9.45-8.5533.51M30.85M
2020-05-05-11.69-10.4918.14M16.05M
2020-02-13-11.39-0.6718.10M15.95M
2019-11-04-10.04-0.8313.15M16.29M
2019-08-06-10.64-0.989.49M13.10M
2019-05-09-16.34-0.87155.00K123.72K
2019-02-28-14.39-13.19206.00K182.40K
2018-11-08-11.84-13.19239.00K269.25K
2018-08-07-9.00-11.3919.89M26.85M
2018-05-10-11.69-10.0410.00M7.95M
2018-03-15-11.99-9.901.53M1.25M
2017-11-02-9.75-0.64—69.91K
2017-08-08-9.60-0.663.00K3.05K
2017-05-04-10.64-0.6768.00K64.17K
2017-03-16-0.65-9.7547.00K47.72K

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-16Abate KristinSell4.79K$0.341.65K
2026-10-01Abate KristinSell378$1.19450
2026-09-01Abate KristinSell19$2.0238
2026-07-28Poulton StuartSell189$7.101.34K
2026-05-21Oliger Christy J.Buy15.51K——
2026-05-21PAKIANATHAN DEEPIKABuy15.51K——
2026-05-21Schor ChenBuy15.51K——
2026-05-21Su ZhenBuy15.51K——
2026-05-21BOHLIN GAREN GBuy15.51K——
2026-05-21Greene Barry EBuy15.51K——
2026-05-14Poulton StuartSell403$9.503.83K
2026-05-14Rangwala ReshmaSell408$9.503.88K
2026-05-14Cheng Sohanya RoshanSell324$9.503.08K
2026-05-14Abate KristinSell53$9.50504
2026-05-14Paulson Richard A.Sell2.20K$9.5020.93K
2026-05-14Mano MichaelSell266$9.502.53K
2026-05-13Poulton StuartBuy896——
2026-05-13Rangwala ReshmaBuy947——
2026-05-13Cheng Sohanya RoshanBuy947——
2026-05-13Abate KristinBuy121——
2026-05-13Paulson Richard A.Buy4.92K——
2026-05-13Mano MichaelBuy700——
2026-04-21Rangwala ReshmaSell449$8.944.01K
2026-03-02Mano MichaelSell3.53K$9.4133.18K
2026-03-02Cheng Sohanya RoshanSell4.60K$9.4143.32K
2026-03-02Rangwala ReshmaSell5.07K$9.4147.67K
2026-03-02Paulson Richard A.Sell12.36K$9.41116.31K
2026-03-02Poulton StuartSell5.10K$9.4148.00K
2026-02-17Poulton StuartSell378$8.633.26K
2026-02-05Paulson Richard A.Buy81.06K——
2026-02-03Macomber LoriSell1.63K$6.3010.24K
2026-01-31Cheng Sohanya RoshanBuy32.41K——
2026-01-31Rangwala ReshmaBuy32.41K——
2026-01-31Macomber LoriBuy32.41K——
2026-01-31Mano MichaelBuy32.41K——
2026-01-31Poulton StuartBuy32.41K——
2026-01-28Abate KristinSell50$7.03352
2026-01-27Abate KristinBuy92——
2026-01-21Abate KristinSell265$5.961.58K
2025-10-15Abate KristinBuy12.80K——
2025-10-15Poulton StuartBuy39.68K——
2025-10-15Mano MichaelBuy43.65K——
2025-10-15Paulson Richard A.Buy114.28K——
2025-10-15Cheng Sohanya RoshanBuy43.65K——
2025-10-15Macomber LoriBuy43.65K——
2025-10-01Abate KristinSell362$6.302.28K
2025-09-15Paulson Richard A.Sell1.26K$6.438.08K
2025-09-15Mano MichaelSell234$6.431.50K
2025-09-15Poulton StuartSell401$6.432.58K
2025-09-15Rangwala ReshmaSell408$6.432.62K
2025-09-15Cheng Sohanya RoshanSell325$6.432.09K
2025-09-15Abate KristinSell23$6.43148
2025-09-12Paulson Richard A.Buy2.80K——
2025-09-12Mano MichaelBuy612——
2025-09-12Poulton StuartBuy888——
2025-09-12Rangwala ReshmaBuy945——
2025-09-12Cheng Sohanya RoshanBuy945——
2025-09-12Abate KristinBuy46——
2025-09-03Abate KristinSell12$6.7881
2025-07-29Poulton StuartSell191$4.37835
2025-07-22Abate KristinSell238$4.00952
2025-05-28Su ZhenBuy4.60K$4.4820.61K
2025-05-28PAKIANATHAN DEEPIKABuy4.60K$4.4820.61K
2025-05-28Oliger Christy J.Buy4.60K$4.4820.61K
2025-05-28Mirza Mansoor RazaBuy4.60K$4.4820.61K
2025-05-28Greene Barry EBuy4.60K$4.4820.61K
2025-05-28Schor ChenBuy4.60K$4.4820.61K
2025-05-28BOHLIN GAREN GBuy4.60K$4.4820.61K
2025-05-06Paulson Richard A.Sell236$7.121.68K
2025-04-23Rangwala ReshmaSell419$6.172.59K
2025-04-04Paulson Richard A.Sell245$3.74916
2025-03-04Mano MichaelSell2.79K$6.2917.57K
2025-02-28Cheng Sohanya RoshanBuy4.58K——
2025-02-28Cheng Sohanya RoshanBuy5.42K——
2025-02-28Cheng Sohanya RoshanBuy10.83K$7.9586.12K
2025-02-28Cheng Sohanya RoshanBuy9.17K$7.9572.87K
2025-02-28Rangwala ReshmaBuy4.58K——
2025-02-28Rangwala ReshmaBuy5.42K——
2025-02-28Rangwala ReshmaBuy10.83K$7.9586.12K
2025-02-28Rangwala ReshmaBuy9.17K$7.9572.87K
2025-02-28Poulton StuartBuy4.58K——
2025-02-28Poulton StuartBuy5.00K——
2025-02-28Poulton StuartBuy10.00K$7.9579.50K
2025-02-28Poulton StuartBuy9.17K$7.9572.87K
2025-02-28Abate KristinBuy933——
2025-02-28Abate KristinBuy1.87K$7.9514.83K
2025-02-28Paulson Richard A.Buy20.00K——
2025-02-28Paulson Richard A.Buy40.00K$7.95318.00K
2025-02-28Mano MichaelBuy2.25K——
2025-02-28Mano MichaelBuy3.33K——
2025-02-28Mano MichaelBuy6.67K$7.9552.99K
2025-02-28Mano MichaelBuy4.50K$7.9535.77K
2025-02-18Poulton StuartSell5.91K$0.633.73K
2025-02-04Paulson Richard A.Sell4.10K$0.652.66K
2025-01-31Macomber LoriBuy650.00K$0.62404.37K
2025-01-31Macomber LoriBuy160.00K——
2025-01-06Paulson Richard A.Sell4.05K$0.783.18K
2025-01-03Macomber LoriOther0——
2024-12-04Paulson Richard A.Sell3.62K$0.812.93K
2024-11-06Abate KristinOther0——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 112, holders +12 vs prior quarter. Ownership 73.18%.

HolderSharesChangeChange %Value
RA CAPITAL MANAGEMENT, L.P.1.92M00.00%18.73M
ADAGE CAPITAL PARTNERS GP, L.L.C.1.52M-285.00K-15.78%14.86M
ACORN CAPITAL ADVISORS, LLC1.52M1.23M+427.44%14.83M
GOLDMAN SACHS GROUP INC1.42M477.08K+50.35%13.92M
BLACKROCK, INC.1.42M1.17M+479.34%13.86M
VANGUARD CAPITAL MANAGEMENT LLC958.98K219.23K+29.64%9.37M
CATALIO CAPITAL MANAGEMENT, LP940.86K43.15K+4.81%9.19M
AVIDITY PARTNERS MANAGEMENT LP924.49K460.75K+99.35%9.03M
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.786.31K-755.78K-49.01%7.68M
TWO SIGMA INVESTMENTS, LP695.26K544.03K+359.73%6.79M
KALEHUA CAPITAL MANAGEMENT LLC685.64K685.64KNew6.70M
NEA MANAGEMENT COMPANY, LLC576.78K576.78KNew5.64M
GEODE CAPITAL MANAGEMENT, LLC531.23K325.10K+157.71%5.19M
GHISALLO CAPITAL MANAGEMENT LLC500.00K500.00KNew4.88M
SUSQUEHANNA INTERNATIONAL GROUP, LLP484.80K460.66K+1908.45%4.74M
SOLEUS CAPITAL MANAGEMENT, L.P.440.00K00.00%4.30M
UBS GROUP AG353.55K159.53K+82.22%3.45M
STATE STREET CORP325.99K245.25K+303.74%3.18M
AFFINITY ASSET ADVISORS, LLC312.50K-187.50K-37.50%3.05M
BREVAN HOWARD CAPITAL MANAGEMENT LP309.82K97.45K+45.89%3.03M
MILLENNIUM MANAGEMENT LLC305.68K214.68K+235.91%2.99M
BOXER CAPITAL MANAGEMENT, LLC302.54K00.00%2.96M
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP300.00K00.00%2.93M
ACADIAN ASSET MANAGEMENT LLC299.00K50.04K+20.10%2.92M
SILVERARC CAPITAL MANAGEMENT, LLC297.46K297.46KNew2.91M

Earnings and financials

Karyopharm Therapeutics Inc. (KPTI) trades at $0.56, with a market cap of $12.72M and a trailing P/E of -0.02. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
15400016050003033600040893000108085000209819000157074000146033000145237000146067000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Karyopharm Therapeutics (KPTI) Financials: Revenue & Earnings

KPTI$0.56+0.08 +16.88%

$12.72M

Market Cap

-0.02

P/E

0.78

Forward P/E

—

Score

Price History